Animals treated with Aβ show impaired ability of learning and memory, activated astrocytes and microglial cells, and disturbed activation of c-JNK and GSK3β [41], suggesting activation of glial cells in AD pathology. This evidence concerns the gene GSK3B and Alzheimer disease.